Company Filing History:
1 out of 3 
1 out of 1 Years Active: 2009-2014
Title: Maria Giovanna Prat: Innovator in Regenerative Medicine
Introduction
Maria Giovanna Prat is a distinguished inventor based in Turin, Italy. She has made significant contributions to the field of regenerative medicine, particularly through her innovative research and patented inventions. With a total of 2 patents, her work focuses on advancing medical technologies and therapeutic applications.
Latest Patents
One of her latest patents is titled "Spontaneously immortalized multipotent mesenchymal cell-line derived from mouse subcutaneous adipose tissue: tool for regenerative medicine and bioactive molecules and/or drugs screening." This invention discloses a spontaneously immortalized multipotent mesenchymal cell-line isolated from mouse subcutaneous adipose tissue. The cell-line exhibits fibroblastoid morphology and expresses various markers, including Sca-1, c-Kit/CD117, nestin, nucleostemin, CD44, and CD106.
Another notable patent is "Anti-HGF-R antibodies and their use." This invention relates to monoclonal antibodies that recognize the chain of the HGF receptor, which has agonist activity similar to that of the natural ligand. The patent also covers the hybridoma that secretes these antibodies and their potential therapeutic and diagnostic applications.
Career Highlights
Maria has worked at the Università degli Studi del Piemonte Orientale "Amedeo Avogadro," where she has contributed to various research projects and initiatives. Her work has been instrumental in advancing the understanding of mesenchymal cell-lines and their applications in regenerative medicine.
Collaborations
Throughout her career, Maria has collaborated with notable colleagues, including Stefano Pietronave and Andrea Zamperone. These collaborations have further enriched her research and expanded the impact of her inventions.
Conclusion
Maria Giovanna Prat is a pioneering inventor whose work in regenerative medicine is shaping the future of medical science. Her innovative patents and collaborations highlight her commitment to advancing healthcare solutions.